MedPath

Evaluation of Hearing Preservation in Adults With Partial Low-Frequency Hearing Implanted With the HiFocus™ Mid-Scala Electrode

Not Applicable
Terminated
Conditions
Hearing Disorders
Deafness
Ear Diseases
Hearing Loss
Otorhinolaryngologic Diseases
Registration Number
NCT01959152
Lead Sponsor
Advanced Bionics
Brief Summary

The purpose of this study is to determine the feasibility of preserving low-frequency acoustic hearing in adults with a moderate degree of hearing loss in the low frequencies and severe-to-profound hearing loss in the mid-to-high frequencies who are implanted with the HiRes™ 90K Advantage implant with HiFocus™ Mid-Scala electrode.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
1
Inclusion Criteria
  • No previous cochlear implant experience
  • 18 years of age or older
  • Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone average ≤ 65 dB HL for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 4,000, and 8,000 Hz) in the ear to be implanted
  • Aided monosyllabic word score of 10-50% in the ear to be implanted
  • Up to a moderate sensorineural hearing loss in the low-to-mid frequencies (pure tone average ≤ 65 dB HL for 125, 250, 500, and 1000 Hz) and a severe-to-profound sensorineural hearing loss in the high frequencies (pure tone average ≥ 70 dB HL for 2,000, 4,000, and 8,000 Hz) in the contralateral (non-implanted) ear
  • English language proficiency
  • Willingness to participate in all scheduled procedures outlined in the protocol
Exclusion Criteria
  • Previous inner ear surgery
  • Cochlear malformation or obstruction that would preclude full insertion of electrode array
  • Presence of additional disabilities that would prevent or interfere with participation in the required study procedures
  • Medical or psychological conditions that contraindicate surgery or impact the ability to manage an implanted device or the study-related procedures
  • Evidence of central auditory lesion or compromised auditory nerve

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Low-frequency unaided acoustic hearing thresholds pre and post implantation with the HiFocus™ Mid-Scala electrode arrayOne month

Unaided low-frequency acoustic hearing thresholds (under earphones) in the implanted ear one month after device activation will be compared to baseline (pre-implant) thresholds in the same ear for audiometric frequencies 125-1000Hz. Threshold changes from baseline will be calculated as:

* Complete preservation of hearing: threshold shift ≤ 15 dB

* Partial preservation of hearing: threshold shift ≥ 16 dB with measurable thresholds

* No preservation of hearing: no measurable thresholds at ≤ 80 dB HL

Secondary Outcome Measures
NameTimeMethod
Word recognition in quiet pre and post implantation with the HiFocus™ Mid-Scala electrode arrayOne month

Word recognition scores in quiet in the implanted ear one month after device activation compared to pre-implant score with a hearing aid

Trial Locations

Locations (3)

Dalhousie University, Department of Surgery, Division of Otolaryngology

🇨🇦

Halifax, Nova Scotia, Canada

The Ottawa Hospital, Parkdale Clinic, Audiology Department

🇨🇦

Ottawa, Ontario, Canada

Sunnybrook Health Sciences Centre, Department of Otolaryngology - Head and Neck Surgery

🇨🇦

Toronto, Ontario, Canada

Dalhousie University, Department of Surgery, Division of Otolaryngology
🇨🇦Halifax, Nova Scotia, Canada

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.